SUNNYVALE, Calif., Feb. 13, 2017 -- Intuitive Surgical, Inc. (Nasdaq:ISRG) today reported that equity awards, approved by the Compensation Committee of the Board of Directors, which consists entirely of Independent Directors, were made to 92 new employees. Pursuant to NASDAQ Marketplace Rule 5635(c)(4), the equity awards were granted under the Intuitive Surgical, Inc. 2009 Commencement Incentive Plan, which the Board of Directors of Intuitive Surgical, Inc. adopted for the granting of equity awards to new employees. In accordance with NASDAQ rules, these grants were made under an equity incentive plan without shareholder approval. NASDAQ rules require a public announcement of equity awards to be made under this type of plan. 92 employees were granted a combination of Restricted Stock Units (RSUs) and Stock Options to purchase an aggregate of 12,456 shares of the Company's common stock; 6,273 of the shares granted were Stock Options and 6,183 of the shares granted were RSUs. Both the RSUs and Stock Options vest over four years. The Stock Options expire in 10 years assuming continued employment. No officers received any award under this plan. The exercise price for the Stock Options granted is $704.24 which was the closing price of Intuitive Surgical, Inc.'s common stock on the NASDAQ Global Market as such price was reported by NASDAQ on February 7, 2017. The Company's policy is to issue RSUs and Stock Option grants to new employees, where equity makes sense, on the fifth business day of every calendar month.
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. (Nasdaq:ISRG), headquartered in Sunnyvale, California, is the global technology leader in robotic-assisted, minimally invasive surgery. Intuitive Surgical develops, manufactures and markets robotic technologies designed to improve clinical outcomes and help patients return more quickly to active and productive lives. The Company's mission is to extend the benefits of minimally invasive surgery to the broadest possible base of patients. Intuitive Surgical - Taking surgery beyond the limits of the human hand™.
About the da Vinci® Surgical System
The da Vinci® System is a breakthrough surgical platform designed to enable complex surgery using a minimally invasive approach. The da Vinci® System consists of an ergonomic surgeon console, a patient-side cart with four interactive robotic arms, a high-performance vision system and proprietary EndoWrist® instruments. Powered by state-of-the-art robotic and computer technology, the da Vinci® System is designed to scale, filter and seamlessly translate the surgeon's hand movements into more precise movements of the EndoWrist® instruments. The net result is an intuitive interface with breakthrough surgical capabilities. By providing surgeons with superior visualization, enhanced dexterity, greater precision and ergonomic comfort, the da Vinci® Surgical System makes it possible for more surgeons to perform minimally invasive procedures involving complex dissection or reconstruction. This ultimately has the potential to raise the standard of care for complex surgeries, translating into numerous potential patient benefits, including less pain, a shorter recovery and quicker return to normal daily activities.
Intuitive®, da Vinci®, da Vinci S®, da Vinci® Si™, InSite® and EndoWrist® are trademarks or registered trademarks of Intuitive Surgical, Inc.
For more information, please visit the company's web site at www.intuitivesurgical.com.
CONTACT: Intuitive Surgical, Inc. Investor Relations 408-523-2161


California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
FDA Approves Mitapivat for Anemia in Thalassemia Patients 



